Mirae Asset Global Investments Co. Ltd. grew its holdings in Oracle Co. (NYSE:ORCL – Free Report) by 39.8% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 542,580 shares of the enterprise software provider’s stock after purchasing an additional 154,441 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in Oracle were worth $64,616,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds have also made changes to their positions in ORCL. Fairfield Bush & CO. lifted its stake in Oracle by 3.1% in the first quarter. Fairfield Bush & CO. now owns 73,791 shares of the enterprise software provider’s stock worth $6,105,000 after acquiring an additional 2,221 shares during the period. AMI Investment Management Inc. boosted its stake in shares of Oracle by 2.9% during the first quarter. AMI Investment Management Inc. now owns 20,467 shares of the enterprise software provider’s stock valued at $1,693,000 after purchasing an additional 579 shares in the last quarter. Baird Financial Group Inc. raised its stake in Oracle by 29.2% in the first quarter. Baird Financial Group Inc. now owns 588,460 shares of the enterprise software provider’s stock worth $48,686,000 after buying an additional 132,920 shares in the last quarter. Zions Bancorporation N.A. boosted its position in Oracle by 79.6% during the 1st quarter. Zions Bancorporation N.A. now owns 6,854 shares of the enterprise software provider’s stock valued at $567,000 after acquiring an additional 3,038 shares in the last quarter. Finally, Covestor Ltd increased its holdings in shares of Oracle by 125.2% in the 1st quarter. Covestor Ltd now owns 1,995 shares of the enterprise software provider’s stock valued at $165,000 after acquiring an additional 1,109 shares during the period. 42.44% of the stock is currently owned by institutional investors.
Oracle Stock Performance
NYSE ORCL opened at $115.36 on Friday. The stock has a market capitalization of $316.01 billion, a price-to-earnings ratio of 34.33, a PEG ratio of 2.92 and a beta of 1.03. Oracle Co. has a twelve month low of $78.06 and a twelve month high of $127.54. The company has a current ratio of 0.87, a quick ratio of 0.87 and a debt-to-equity ratio of 29.72. The stock has a 50-day moving average of $108.95 and a 200 day moving average of $111.52.
Oracle Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Thursday, October 26th. Shareholders of record on Thursday, October 12th were issued a dividend of $0.40 per share. The ex-dividend date of this dividend was Wednesday, October 11th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.39%. Oracle’s payout ratio is currently 47.62%.
Analyst Upgrades and Downgrades
A number of brokerages recently weighed in on ORCL. Jefferies Financial Group raised their price objective on Oracle from $135.00 to $145.00 and gave the company a “buy” rating in a research report on Thursday, September 7th. Piper Sandler reaffirmed an “overweight” rating and set a $130.00 price target on shares of Oracle in a research report on Friday, September 22nd. Monness Crespi & Hardt cut Oracle from a “buy” rating to a “neutral” rating in a research report on Tuesday, September 12th. Morgan Stanley raised their price target on Oracle from $106.00 to $107.00 and gave the stock an “equal weight” rating in a report on Monday, October 23rd. Finally, Barclays decreased their price objective on shares of Oracle from $150.00 to $147.00 and set an “overweight” rating for the company in a research report on Tuesday, September 12th. Eleven analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $124.23.
Check Out Our Latest Analysis on Oracle
Insider Buying and Selling at Oracle
In other Oracle news, Director George H. Conrades sold 2,325 shares of the stock in a transaction that occurred on Friday, November 10th. The stock was sold at an average price of $111.97, for a total transaction of $260,330.25. Following the completion of the transaction, the director now owns 20,161 shares of the company’s stock, valued at $2,257,427.17. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 42.80% of the company’s stock.
Oracle Profile
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Featured Stories
- Five stocks we like better than Oracle
- How and Why to Invest in Oil Stocks
- MarketBeat Week in Review – 11/13 – 11/17
- Quiet Period Expirations Explained
- 3 large caps with red hot RSIs with upside
- How to Invest in Cybersecurity
- Johnson Controls International: Nothing but upside for investors
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Co. (NYSE:ORCL – Free Report).
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.